Richardson Ryan — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Richardson Ryan has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Richardson Ryan serves as a director of Autolus Therapeutics plc, a clinical-stage biopharmaceutical company focused on engineered T-cell therapies. The SEC filing dated 2026-07-01 lists him in the role of Director for Autolus Therapeutics plc, indicating involvement in board governance, oversight of strategy, and corporate fiduciary responsibilities at the company.

Board memberships

• Autolus Therapeutics plc

Awards & honors

• Director of Autolus Therapeutics plc as of the 2026 SEC filing
• Participation in board-level governance and oversight for a public biopharma company

Companies — Last 90 Days

• Autolus Therapeutics plc (AUTL) — 1 filings, last 2026-07-01

Frequently Asked Questions

Who is Richardson Ryan?

Richardson Ryan serves as a director of Autolus Therapeutics plc, a clinical-stage biopharmaceutical company focused on engineered T-cell therapies. The SEC filing dated 2026-07-01 lists him in the role of Director for Autolus Therapeutics plc, indicating involvement in board governance, oversight of strategy, and corporate fiduciary responsibilities at the company.…

How many SEC Form 4 filings has Richardson Ryan submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Richardson Ryan's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week